Literature DB >> 18452499

Swedish norms for word fluency tests: FAS, animals and verbs.

I M Tallberg1, E Ivachova, K Jones Tinghag, P Ostberg.   

Abstract

Verbal fluency tests are useful measures of acquired language impairment and cognitive decline of various etiologies. The aim of this study was to provide normative data for the Swedish population on the three verbal fluency tests, FAS, Animals and Verbs. A group of 165 healthy participants ranging from 16 to 89 years of age were assessed with the verbal fluency tests and tests of level of intellectual functioning. The sample was stratified by education, age and gender. Level of education had a substantial influence on the performance on verbal fluency, most clearly so in FAS and Verbs. Intellectual level had a positive and significant correlation with all measures of word fluency. Moreover, there was an interaction between age and gender such that women aged between 30 and 64 years outperformed elderly men on FAS and Verbs. Guidelines for instructions and scoring in Swedish are given in the article.

Entities:  

Mesh:

Year:  2008        PMID: 18452499     DOI: 10.1111/j.1467-9450.2008.00653.x

Source DB:  PubMed          Journal:  Scand J Psychol        ISSN: 0036-5564


  28 in total

Review 1.  A Systematic Review of Normative Data for Verbal Fluency Test in Different Languages.

Authors:  Dolores Villalobos; Lucia Torres-Simón; Javier Pacios; Nuria Paúl; David Del Río
Journal:  Neuropsychol Rev       Date:  2022-09-13       Impact factor: 6.940

2.  A new standardization of semantic verbal fluency test.

Authors:  Barbara Zarino; Marta Crespi; Michela Launi; Alessandra Casarotti
Journal:  Neurol Sci       Date:  2014-04-06       Impact factor: 3.307

3.  Demographically-adjusted norms for selected tests of verbal fluency: Results from the Neuropsychological Norms for the US-Mexico Border Region in Spanish (NP-NUMBRS) project.

Authors:  María J Marquine; Alejandra Morlett Paredes; Cecilia Madriaga; Yanina Blumstein; Anya Umlauf; Lily Kamalyan; Monica Rivera Mindt; Paola Suarez; Lidia Artiola I Fortuni; Robert K Heaton; Mariana Cherner
Journal:  Clin Neuropsychol       Date:  2020-06-04       Impact factor: 3.535

Review 4.  Language Development across the Life Span: A Neuropsychological/Neuroimaging Perspective.

Authors:  Mónica Rosselli; Alfredo Ardila; Esmeralda Matute; Idaly Vélez-Uribe
Journal:  Neurosci J       Date:  2014-12-18

5.  Computerized Analysis of Verbal Fluency: Normative Data and the Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury.

Authors:  David L Woods; John M Wyma; Timothy J Herron; E William Yund
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

6.  Multifaceted Communication Problems in Everyday Conversations Involving People with Parkinson's Disease.

Authors:  Charlotta Saldert; Malin Bauer
Journal:  Brain Sci       Date:  2017-09-25

7.  Phonemic verbal fluency task in adults with high-level literacy.

Authors:  Patrícia Romano Opasso; Simone Dos Santos Barreto; Karin Zazo Ortiz
Journal:  Einstein (Sao Paulo)       Date:  2016 Jul-Sep

8.  Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey.

Authors:  Ana Luisa Sosa; Emiliano Albanese; Martin Prince; Daisy Acosta; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Juan Llibre de Rodriguez; Aquiles Salas; Fang Yang; Ciro Gaona; At Joteeshwaran; Guillermina Rodriguez; Gabriela Rojas de la Torre; Joseph D Williams; Robert Stewart
Journal:  BMC Neurol       Date:  2009-08-26       Impact factor: 2.474

9.  Semantic trouble sources and their repair in conversations affected by Parkinson's disease.

Authors:  Charlotta Saldert; Ulrika Ferm; Steven Bloch
Journal:  Int J Lang Commun Disord       Date:  2014-06-16       Impact factor: 3.020

10.  18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.

Authors:  Ruben Smith; Michael Schöll; Elisabet Londos; Tomas Ohlsson; Oskar Hansson
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.